ArticleScientific reports2025
High-performance terahertz biosensor utilizing a hybrid one-dimensional photonic crystal with liquid crystal and graphene components.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent decades, advances in biophotonics research have led to the development of numerous novel applications, particularly in the realm of diagnostic tools. Among these, one-dimensional photonic crystal biosensors have emerged as frequently utilized instruments for disease diagnosis and sensing. A significant body of research has focused on enhancing the efficiency of these biosensors. Recently, integration of Graphene and liquid crystal into a hybrid structure has been identified as a promising approach for the advancement of optical devices. This study presents a novel one-dimensional photonic crystal biosensor designed using the Kretschmann configuration, which incorporates Graphene nanolayers and a liquid crystal layer. The transfer matrix method was employed to calculate the projected band structure of the designed biosensor for different chemical potentials of the Graphene nanolayers. Additionally, the dispersion properties of the surface waves can be tuned by adjusting the liquid crystal director angle. By manipulating the adjustable parameters of the Graphene nanolayer and liquid crystal, modifications to the reflection spectrum can be achieved, facilitating an analysis of angular sensitivity and figure of merit. The results indicate that these parameters significantly influence sensitivity and figure of merit of the biosensor. Notably, increases in the chemical potential of the Graphene nanolayers, along with adjustments to the liquid crystal director angle, substantially enhance the performance of the biosensor. Our study achieved a maximum sensitivity of [Formula: see text] at a graphene chemical potential of [Formula: see text] and a liquid crystal orientation angle of [Formula: see text]. Additionally, a maximum figure of merit of [Formula: see text] was obtained at a chemical potential of [Formula: see text] and an orientation angle of [Formula: see text]. The proposed sensor is deemed suitable for practical applications due to its straightforward fabrication process and capability to operate at room temperature. Moreover, the properties of both the Graphene nanolayers and the liquid crystal layer in the biosensor can be readily adjusted, further contributing to its versatility and efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.